8:45 WELCOME COFFEE

​

9:30 : Opening Speech by Isabelle DIMIER-POISSON

​

 

 PART I : Overview and therapies

​

9:45-10:10 : Daniel MARC (INRA - Avian immune response and pathogenesis - TOURS)

          Viruses: tireless, undisciplined explorers of life.

​

10:15-10:45 : Olivier REYNARD (CIRI – Molecular bases of viral pathology – LYON)

          Ebola virus infection: toward a better understanding of the initial steps.

​

BREAK 20 min (10:45–11:05)

​

11:10-11:40 : Jade COCHARD  (INSERM – MAVIVH – TOURS)

           Cell culture production of HCV particles highly infectious and morphologically similar to naïve HCV particles.

 

 

11:45-12:15 :  Karl STEFIC (INSERM – MAVIVH – TOURS)

          Monitoring the sensitivity to broadly neutralizing antibodies of HIV-1 strains transmitted in France.

​

LUNCH TIME (12:15–13:45)

​

PART II : Viruses as therapeutic solutions

 

13:45–14:15 : Jérémy BEGUIN (National Veterinary School of Alfort – TRANSGENE – PARIS)

          New therapeutic strategy using a double deleted oncolytic Vaccinia virus encoding FCU1 protein (TG6002)
against canine cancers

​

14:20–14:50 :  Karim BENIHOUD (Institute Gustave ROUSSY – Viral Vectorology – PARIS)

           Vaccination by epitope display on adenovirus capsid

​

BREAK 20 min (14:55–15:15)

​

15:15–15:45 : Catherine SCHOULER (INRA – Pathogenesis of avian colibacillosis – TOURS)

          Biocontrol of avian colibacillosis by phages

​

15:50–16:20 : Martine CERUTTI (Labex MabImprove – Baculovirus and therapy – MONTPELLIER)

       A new baculovirus expression system for the production of highly glycosylated multi-subunit proteins :
application to the production of antibody, antibody-derived molecules and vaccines

​

16:25 CLOSING SPEECH 

​

Closing ceremony

​